Učitavanje...

Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody–Associated Encephalopathy

IMPORTANCE: This observational study describes the efficacy and safety of rituximab in 5 patients with voltage-gated potassium channel (VGKC)–complex/leucine-rich, glioma-inactivated 1 (LGI1) antibody–associated encephalopathy. Rituximab is a monoclonal antibody that targets CD20 and is used to trea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Neurol
Glavni autori: Irani, Sarosh R., Gelfand, Jeffrey M., Bettcher, Brianne M., Singhal, Neel S., Geschwind, Michael D.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477824/
https://ncbi.nlm.nih.gov/pubmed/24842754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2014.463
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!